Your browser doesn't support javascript.
loading
Selpercatinib monotherapy in a Chinese patient with RET fusion/ EGFR co-mutated nonsmall cell lung cancer from the Phase II LIBRETTO-321 study: a case report.
Wu, Lin; Cheng, Ying; Huang, Dingzhi; Sun, Yuping; Zhou, Chengzhi; Zhou, Jianying; Guo, Ye; Shao, Jingxin; Zhang, Wanli; Lu, Shun.
Afiliação
  • Wu L; Department II of Thoracic Medicine, Hunan Cancer Hospital.
  • Cheng Y; Department of Thoracic Oncology, Jilin Cancer Hospital, Changchun.
  • Huang D; Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin.
  • Sun Y; Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, Jinan.
  • Zhou C; Respiratory Medicine Department, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou.
  • Zhou J; Department of Respiratory Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou.
  • Guo Y; Department of Medical Oncology, Shanghai East Hospital, Tongji University School of Medicine.
  • Shao J; Oncology, Eli Lilly and Company.
  • Zhang W; Oncology, Eli Lilly and Company.
  • Lu S; Department of Medical Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Anticancer Drugs ; 34(9): 1058-1064, 2023 10 01.
Article em En | MEDLINE | ID: mdl-37265026

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article